Management of cirrhotic ascites: Physiological basis of diuretic action

European Journal of Internal Medicine

Volumn 17, Issue 1, 2006, Pages 8-19

  Rosner, Mitchell H ^a   Gupta, Rohit ^a   Ellison, David ^b   Okusa, Mark D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Ascites; Cirrhosis; Diuretic resistance; Diuretics

Indexed keywords

ALBUMIN; ALDOSTERONE ANTAGONIST; AMILORIDE; BUMETANIDE; CHLORTALIDONE; DIURETIC AGENT; EPLERENONE; ETACRYNIC ACID; FUROSEMIDE; LOOP DIURETIC AGENT; SODIUM CHLORIDE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE; TRIAMTERENE;

ASCITES; BRAIN DISEASE; DIURESIS; DRUG MECHANISM; EXTRACELLULAR FLUID; GYNECOMASTIA; HIRSUTISM; HUMAN; HYPOKALEMIA; HYPONATREMIA; IMPOTENCE; KIDNEY COLLECTING TUBULE; KIDNEY DISTAL TUBULE; KIDNEY FAILURE; KIDNEY TUBULE ABSORPTION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MENSTRUAL IRREGULARITY; METABOLIC ALKALOSIS; MORTALITY; MUSCLE CRAMP; NONHUMAN; PARACENTESIS; PATHOPHYSIOLOGY; PERITONEUM VEIN SHUNT; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; REVIEW; SODIUM RESTRICTION; SODIUM RETENTION; WATER ABSORPTION;

EID: 29344458316     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2005.08.003     Document Type: Review

References (138)

1. B.A. Runyon Management of adult patients with ascites caused by cirrhosis Hepatology 27 1998 264 272
2. M.H. Witte, C.L. Witte, and A.E. Dumont Progress in liver disease: physiological factors involved in the causation of cirrhotic ascites Gastroenterology 61 1971 742 750
3. M. Atkinson, and M.S. Losowsky The mechanism of ascites formation in chronic liver disease QJM 30 1961 153 166
4. A. Cardenas, and P. Gines Pathogenesis and treatment of fluid and electrolyte imbalance in cirrhosis Semin Nephrol 21 2001 308 316
5. V. Arroyo, P. Gines, and R. Planas Pathogenesis, diagnosis and treatment of ascites in cirrhosis J. Bircher J.P. Benhamou N. McIntyre Oxford textbook of clinical hepatology 2nd ed. 1999 Oxford University Press 697 720
6. J. Bosch, J.C. Garcia-Pagan, F. Feu, and M.P. Pizcueta Portal hypertension J. Prieto J. Rodes D.A. Shafritz Hepatobiliary diseases 1992 Springer-Verlag Berlin
7. H.J. Grossman, V.L. Grossman, and P.S. Bhathal Intrahepatic vascular resistance in cirrhosis J. Bosch R.J. Groszmann Portal hypertension: pathophysiology and treatment 1994 Blackwell Scientific Publications Oxford
8. W.G. Rector Jr. Portal hypertension: a permissive factor only in the development of ascites and variceal bleeding Liver 6 1986 221 226
9. G.A. Morali, K.W. Sniderman, and K.M. Deitel Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites? J Hepatol 16 1992 249 250
10. J. Bosch, R. Enriquez, R.J. Groszmann, and E.H. Storer Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model Hepatology 3 1983 1002 1007
11. J. Zink, and C.V. Greenway Intraperitoneal pressure in formation and reabsorption of ascites in cats Am J Physiol 223 1977 H185
12. P. Gines, G. Fernadez-Esparrach, V. Arroyo, and J. Rodes Pathogenesis of ascites in cirrhosis Semin Liver Dis 17 1997 175 189
13. B.F. Palmer Pathogenesis of ascites and renal salt retention in cirrhosis J Investig Med 47 1999 183 202
14. B. Runyon, A. Montano, E. Akriviadis, M.R. Antillon, M.A. Irving, and J.G. McHutchinson The serum ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites Ann Intern Med 117 1992 215 220
15. F. Scaffner, and H. Popper Capillarization of hepatic sinusoids in man Gastroenterology 44 1963 239 243
16. R.J. Korthuis, D.A. Kinden, G.E. Brimer, K.A. Slattery, P. Stogsdill, and D.N. Granger Intestinal capillary filtration in acute and chronic portal hypertension Am J Physiol 254 1998 G339 G345
17. M. Levy Sodium retention and ascites formation in dogs with experimental portal cirrhosis Am J Physiol 233 1977 F572 F585
18. M. Levy, and J.B. Allotey Temporal relationships between urinary salt retention and altered systemic hemodynamics in dogs with experimental cirrhosis J Lab Clin Med 92 1978 560 569
19. W.J. Eisenmenger, S.H. Blondheim, A.M. Bongiovanni, and H.G. Kunkel Electrolyte studies on patients with cirrhosis of the liver J Clin Invest 29 1950 1491 1499
20. A.V.N. Goodyer, A.S. Relman, F.D. Lawrason, and F.H. Epstein Salt retention in cirrhosis of the liver J Clin Invest 29 1950 973 981
21. M. Epstein Deranged sodium homeostasis in cirrhosis Gastroenterology 76 1979 622 635
22. R. Naccarato, P. Messa, and A. D'Angelo Renal handling of sodium and water in early chronic liver disease Gastroenterology 81 1981 205 210
23. M. Epstein Renal sodium handling in liver disease M. Epstein The kidney in liver disease 4th edition 1996 Hanley and Belfus Philadelphia
24. J.F. Murray, A.M. Dawson, and S. Sherlock Circulatory changes in chronic liver disease Am J Med 32 1958 358 367
25. F.L. Lieberman, E.K. Denison, and T.B. Reynolds The relationship of plasma volume, portal hypertension, ascites and renal sodium retention in cirrhosis: the overflow theory of ascites formation Ann N Y Acad Sci 170 1970 202 212
26. P.E. Sawchenko, and M.I. Friedman Sensory functions of the liver: a review Am J Physiol 236 1979 R5 R20
27. W.H.H. Andrews, and J.F. Palmer Afferent nervous discharge from the canine liver Q J Exp Physiol 52 1967 269 276
28. R.W. Schrier, V. Arroyo, M. Bernardi, M. Epstein, J.H. Hennriksen, and J. Rodes Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal and sodium water retention in cirrhosis Hepatology 5 1988 1151 1157
29. W.G. Rector, and K.F. Hossack Pathogenesis of sodium retention complicating cirrhosis: is there room for diminished effective arterial blood volume? Gastroenterology 95 1988 1658 1663
30. J. Bosch, V. Arroyo, and A. Betria Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrosis Gastroenterology 78 1980 92 99
31. L. Rosoff, P. Zia, T. Reynolds, and R. Horton Studies of renin and aldosterone in cirrhotic patients with ascites Gastroenterology 69 1975 698 705
32. D.G. Bichet, V.J. Van Putten, and R.W. Schrier Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis N Engl J Med 307 1982 1157 1552
33. J.H. Henriksen, F. Bendtsen, A.L. Gerbes, N.J. Christensen, H. Ring-Larsen, and T.I. Sorensen Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor Hepatology 5 1992 1163 1170
34. J.H. Henriksen, F. Bendtsen, and T.I.A. Sorenson Reduced central blood volume in cirrhosis Gastroenterology 97 1989 1506 1513
35. S. Moller, and J.H. Henriksen Circulatory abnormalities in cirrhosis with focus on neurohumoral aspects Semin Nephrol 17 1997 505 519
36. H.A. Kontos, W. Shapiro, H.P. Mauck, and J.L. Patterson General and regional circulatory alterations in cirrhosis of the liver Am J Med 37 1964 526 535
37. M. Niederberger, P.Y. Martin, and P. Gines Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in rats with cirrhosis and ascites Gastroenterology 109 1995 1624 1630
38. S. Battista, F. Bar, G. Mengozzi, E. Zanon, M. Grosso, and G. Molino Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins J Hepatol 26 1997 75 80
39. F.L.M. Ricciardolo, P.J. Sterk, B. Gaston, and G. Folkerts Nitric oxide in health and disease of the respiratory system Physiol Rev 84 2004 731 765
40. J.C. Sullivan, A.D. Giulumian, and D.M. Pollock Functional NOS 1 in the rat mesenteric arterial bed Am J Physiol Heart Circ Physiol 283 2002 H658 H663
41. L. Xu, E.P. Carter, and M. Ohara Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis Am J Physiol Renal Physiol 279 2000 1110 1115
42. J. Such, D.J. Hillebrand, and C. Guarner Nitric oxide in ascitic fluid is an independent predictor of the development of renal impairment in patients with cirrhosis and spontaneous bacterial peritonitis Eur J Gastroenterol Hepatol 16 2004 571 577
43. J. Henriksen, F. Bendtsen, A.L. Gerbes, N.J. Christensen, H. Ring-Larsen, and T.I. Sorensen Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor Hepatology 16 1992 1163 1170
44. M. Epstein Renal effects of head-out water immersion in humans: a 15-yr update Physiol Rev 72 1992 563 621
45. D.G. Bichet, B.M. Groves, and R.W. Schrier Mechanisms of improvement of water and sodium excretion by immersion in decompensated cirrhotic patients Kidney Int 24 1983 788 794
46. M. Epstein Cardiovascular and renal effects of head-out water immersion in man Circ Res 39 1976 619 628
47. M. Epstein Renin-angiotensin system in liver disease M. Epstein The kidney in liver disease 4th edition 1996 Hanley and Belfus Philadelphia
48. A. Cardenas, and P. Gines Pathogenesis and treatment of fluid and electrolyte imbalance in cirrhosis Semin Nephrol 21 2001 308 316
49. D.G. Bichet, V. Szatalowicz, C. Chaimovitz, and R.W. Schrier Role of vasopressin in abnormal water excretion in cirrhotic patients Ann Intern Med 96 1982 413 417
50. S. Neilsen, J. Frokiaer, and D. Marples Aquaporins in the kidney: from molecules to medicine Physiol Rev 82 2002 205 244
51. V. Arroyo, J. Rodes, M.A. Guiterrez-Lizarraga, and L. Revert Prognostic value of spontaneous hyponatremia in cirrhosis with ascites Am J Dig Dis 21 1976 249 256
52. + exchanger isoform of the brush border Am J Physiol 265 1993 F736 F742
53. +-2Cl-cotransporter, BSC-1 Am J Physiol 271 1996 F619 F628
54. C.A. Ecelbarger, J.B. Wade, and J. Terris Localization and regulation of bumetanide-sensitive cotransporter protein in rat kidney J Am Soc Nephrol 6 1995 335 [abstract]
55. M.R. Kaplan, M.D. Plotkin, and W.S. Lee Apical localization of the Na-K-Cl cotransporter, rBSC1, on rat thick ascending limbs Kidney Int 49 1996 40 47
56. N. Obermuller, P.L. Bernstein, and H. Velazquez Expression of the thiazide-sensitive Na-Cl cotransporter in rat and human kidney Am J Physiol 269 1995 F900 F910
57. M.D. Plotkin, M.R. Kaplan, and J.W. verlander Localization of the thiazide sensitive Na-Cl cotransporter, rTSC1, in the rat kidney Kidney Int 50 1996 174 183
58. C. Duc, N. Farman, C.M. Canessa, J.P. Bonvalet, and B.C. Rossier Cell-specific expression of epithelial sodium channel alpha, beta and gamma subunits in aldosterone-responsive epithelia from the rat: localization by in situ hybridization and immunocytochemistry J Cell Biol 127 1994 1907 1921
59. M.D. Okusa, and D.H. Ellison Physiology and pathophysiology of diuretic action D.W. Seldin G. Giebisch The kidney: physiology and pathophysiology 2000 Lippincott Williams and Wilkins Philadelphia
60. M. Haas, and T.J. McManus Bumetanide inhibits (Na+K+2Cl) co-transport as a chloride site Am J Physiol 245 1983 C235 C240
61. P. Isenring, and B. Forbush III Ion and bumetanide binding by the Na-K-Cl cotransporter: importance of transmembrane domains J Biol Chem 272 1997 24556 24562
62. R.N. Khuri, M. Wiederholt, N. Streider, and G. Giebisch Effects of graded solute diuresis on renal tubular sodium transport in the rat Am J Physiol 228 1975 1262 1268
63. S.C. Hebert, W.B. Reeves, D.A. Molony, and T.E. Andreoli The medullary thick limb: function and modulation of the single-effect multiplier Kidney Int 31 1987 580 588
64. J.B. Hook, A.H. Blatt, M.J. Brody, and H.E. Williamson Effects of several saluretic-diuretic agents on renal hemodynamics J Pharmacol Exp Ther 154 1966 667 673
65. R.G. Dluhy, G.L. Wolf, and D.P. Lauler Vasodilator properties of ethacrynic acid in the perfused dog kidney Clin Sci 38 1970 347 357
66. J.H. Ludens, J.B. Hook, M.J. Brody, and H.E. Williamson Enhancement of renal blood flow by furosemide J Pharmacol Exp Ther 163 1968 456 460
67. F.S. Wright, and J. Schnermann Interference with feedback control of glomerular filtration rate by furosemide, triflocin, and cyanide J Clin Invest 53 1974 1695 1708
68. D.C. Brater Diuretic pharmacokinetics and pharmacodynamics D.W. Seldin G. Giebisch Diuretic agents: clinical physiology and pharmacology 1997 Academic Press San Diego 495 512
69. M. Inoue, K. Okajima, K. Itoh, and Y. Ando Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients Kidney Int 32 1987 198 203
70. G. Gonzalez, A. Arancibia, M.I. Rivas, P. Caro, and P. Antezano Pharmacokinetics of furosemide in patients with hepatic cirrhosis Eur J Clin Pharmacol 22 1982 315 320
71. S. Schwartz, D.C. Brater, D. Pound, P.K. Greene, W.G. Kramer, and D. Rudy Bioavailability, pharmacokinetics and pharmacodynamics of torsemide in patients with cirrhosis Clin Pharmacol Ther 54 1993 90 97
72. A.L. Marcantonio, W.H.R. Auld, and W.R. Murdock The pharmacokinetics and pharmacodynamics of the diuretic bumetanide in hepatic and renal disease Br J Clin Pharmacol 15 1983 245 252
73. K.H. Beyer Jr. The mechanism of action of chlorothiazide Ann N Y Acad Sci 71 1958 363 379
74. K.H. Beyer Jr., and J.E. Baer The site and mode of action of some sulfonamide-derived diuretics Med Clin North Am 59 1975 735 750
75. R.T. Kunau Jr., D.R. Weller, and H.I. Webb Clarification of the site of action of chlorothiazide in the rat nephron J Clin Invest 56 1975 401 407
76. S.J. Walter, and D.G. Shirley The effect of chronic hydrochlorothiazed administration on renal function in the rat Clin Sci 70 1986 379 387
77. D. Siegel, S.B. Hulley, and D.M. Black Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men JAMA 267 1992 1083 1089
78. C.V.S. Ram, B.N. Garrett, and N.M. Kaplan Moderate sodium restriction and various diuretics in the treatment of hypertension: effects of potassium wastage and blood pressure control Arch Intern Med 141 1981 1015 1019
79. H. Garty, and L.G. Palmer Epithelial sodium channels: function, structure and regulation Physiol Rev 77 1997 359 396
80. J.E. Baer, C.B. Jones, S.A. Spitzer, and H.F. Russo The potassium sparing and natriuretic activity of amidino-3,4-diamino-6-chloropyrazinecarboxamide hydrochloride dihydrate (amiloride hydrochloride) J Pharmacol Exp Ther 157 1967 472 485
81. J.B. Gross, and J.P. Kokko Effects of aldosterone and potassium-sparing diuretics on electrical potential differences across the distal nephron J Clin Invest 59 1977 82 89
82. J.P. Guignard, and G. Peters Effects of triamterence and amiloride on urinary acidification and potassium excretion in the rat Eur J Pharmacol 10 1970 255 267
83. I. Rubera, J. Loffing, and L.G. Palmer Collecting duct-specific gene inactivation of alphaENaC in the mouse kidney does not impair sodium and potassium balance J Clin Invest 112 2003 554 565
84. G. Laffi, G. LaVilla, and V. Carloni Loop diuretic therapy in liver cirrosis with ascites J Cardiovasc Pharmacol 22 Suppl. 3 1993 S51 S58
85. M. Botero-Velez, J.J. Curtis, and D.G. Warnock Brief report: Liddle's syndrome revisited: a disorder of sodium reabsorption in the distal tubule N Engl J Med 174 1994 178 181
86. M.D. Okusa, and M.J. Bia Barrter's syndrome P.P. Foa M.P. Cohen Biology and metabolism 1987 Springer-Verlag New York 231 263
87. D.D. Fanestil Mechanism of action of aldosterone blockers Semin Nephrol 8 1988 249 263
88. C.R. Shackelton, N.L.M. Wong, and R.A. Sutton Distal (potassium-sparing) diuretics J.A. Dirks R.A.L. Sutton Diuretics: physiology, pharmacology and clinical use 1986 WB Saunders Philadelphia 117 134
89. P. Corvol, M. Claire, M.E. Oblin, K. Geering, and B. Rossier Mechanism of the antimineralocorticoid effects of spironolactones Kidney Int 20 1981 1 6
90. G.W. Liddle Aldosterone antagonists and triamterene Ann N Y Acad Sci 134 1966 460 466
91. 3H]spironolactone (SC26304) Proc Natl Acad Sci U S A 71 1974 1431 1435
92. + transport and RNA metabolism in toad bladder epithelium J Membr Biol 32 1977 170 177
93. B. Couette, M. Lombes, E.-E. Baulieu, and M.E. Rafestin-Oblin Aldosterone antagonists destabilize the mineralocorticoid receptor Biochem J 282 1992 697 702
94. C.M. Kagawa Blocking the renal electrolyte effects of mineralocorticoids with an orally active steroidal spironolactone Endocrinology 65 1960 125 132
95. G.W. Liddle Specific and nonspecific inhibition of the mineralocorticoid activity Metabolism 10 1961 1021 1030
96. W.S. Coppage, and G.W. Liddle Mode of action and clinical usefulness of aldosterone antagonists Ann N Y Acad Sci 88 1960 810 815
97. I. Sungaila, W.R. Bartle, and S.E. Walker Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites Gastroenterology 102 1992 1680 1685
98. C. Allgulander, B. Beermann, and A. Sjogren Furosemide pharmacokinetics in patients with liver disease Clin Pharmacokinet 5 1980 570 575
99. V.K. Sawhney, P.B. Gregory, S.E. Swezey, and T.F. Blaschke Furosemide disposition in cirrhotic patients Gastroenterology 81 1981 1012 1016
100. J. Delyani Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology Kidney Int 57 2000 1408 1411
101. S. Rajagopalan, and B. Pitt Aldosterone antagonists in the treatment of hypertension and target organ damage Curr Hypertens Rep 3 2001 240 248
102. M.H. Weinberger, B. Roniker, S.L. Krause, and R.J. Weiss Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension Am J Hypertens 15 2002 709 716
103. A.J. Zillich, and B.L. Carter Eplerenone: a novel selective aldosterone blocker Ann Pharmacother 36 2002 1567 1576
104. E.T. Schroeder, G.H. Anderson, S.H. Goldman, and D.H. Streeten Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis Kidney Int 9 1976 511 519
105. V. Arroyo, J. Bosch, M. Mauri, F. Ribera, F. Navarro-Lopez, and J. Rodes Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites Eur J Clin Invest 11 1981 221 229
106. A.M. Chonko, W.H. Bay, J. Stein, and T.F. Ferris The role of renin and aldosterone in the salt retention of edema Am J Med 63 1977 881 889
107. M. Epstein, R. Levinson, J. Sancho, E. Haber, and R. Re Characterization of the renin-aldosterone system in decompensated cirrosis Circ Res 41 1977 818 829
108. E. Keller, G. Hoppe-Seyler, R. Mumm, and P. Schollmeyer Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide Eur J Clin Pharmacol 20 1981 27 33
109. A. Traeger, R. Hantze, and M. Penzlin Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosis Int J Clin Pharmacol Ther Toxicol 23 1985 129 133
110. S. Schwartz, D.C. Brater, D. Pound, P.K. Greene, W.G. Kramer, and D. Rudy Bioavailability, pharmacokinetics and pharmacodynamics of torsemide in patients with cirrhosis Clin Pharmacol Ther 54 1993 90 97
111. A.L. Marcantonio, W.H.R. Auld, and W.R. Murdock The pharmacokinetics and pharmacodynamics of the diuretic bumetanide in hepatic and renal disease Br J Clin Pharmacol 15 1983 245 252
112. J.P. Villeneuve, R.K. Verbeeck, G.R. Wilkinson, and R.A. Branch Furosemide kinetics and dynamics in patients with cirrhosis Clin Pharmacol Ther 40 1986 14 20
113. M. Inoue, K. Okajima, and K. Itoh Mechanisms of furosemide resistance in analbuminemic rats and hypoalbuminemic patients Kidney Int 32 1987 198 203
114. C. Allgulander, B. Beernmann, and A. Sjogren Frusemide pharmacokinetics in patients with liver disease Clin Pharmacokinet 5 1980 570 575
115. B.A. Runyon Management of adult patients with ascites caused by cirrhosis Hepatology 27 1998 264 272
116. W.J. Eisenmenger, E.H. Ahrens, and S.H. Blondheim The effect of rigid sodium restriction in patients with cirrhosis of the liver and ascites J Lab Clin Med 34 1949 1029 1038
117. F. Trevisani, M. Bernardi, and G. Gasbarrini Bed-rest induced hypernatriuresis in cirrhotic patients without ascites: does it contribute to maintain compensation? J Hepatol 16 1992 190 196
118. J. Salo, M. Guevara, and G. Fernandez-Esparrach Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites; relationship with the activity of neurohormonal systems Hepatology 25 1997 1338 1342
119. L. Shear, S. Ching, and G.J. Gabuzda Compartmentalization of ascites and edema in patients with hepatic cirrhosis N Engl J Med 282 1970 1391 1396
120. P.J. Pockros, and T.B. Reynolds Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema Gastroenterology 90 1986 1827 1833
121. M.R. Fogel, V.K. Sawhney, E.A. Neal, R.G. Miller, C.M. Knauer, and P.B. Gregory Diuresis in the ascitic patient: a randomized controlled trial of three regimens J Clin Gastroenterol 3 Suppl. 1 1981 73 80
122. R.M. Perez-Ayuso, V. Arroyo, and R. Planas Randomized comparative study of efficacy of furosemide vs. spironolactone in nonazotemic cirrhosis with ascites Gastroenterology 84 1983 961 968
123. B.A. Runyon Patient selection is important in studying the impact of large-volume paracentesis on intravascular volume Am J Gastroenterol 92 1997 371 373
124. N. Chalasani, C. Gorski, J.C. Horlander, R. Craven, and H. Hoen Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients J Am Soc Nephprol 12 2001 1010 1016
125. F. Akcicek, T. Yalniz, A. Basci, E. Ok, and E.J. Mess Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin? Br Med J 310 1995 162 163
126. D. Fliser, I. Zurbruggen, and E. Mutschler Coadministration of albumin and furosemide in patients with the nephrotic syndrome Kidney Int 55 1999 629 634
127. E.J.D. Mees Does it make sense to administer albumin to the patient with nephrotic edema? Nephrol Dial Transplant 11 1996 1224 1226
128. J. Prandota Urinary elimination kinetics and diuretic effect of intravenous furosemide in nephrotic children Dev Pharmacol Ther 5 1982 98 108
129. S. Moller, F. Bendtsen, and J.H. Henriksen Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis Gastroenterology 109 1995 1917 1925
130. N. Chalasani, J.C. Gorski, and J.C. Horlander Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients J Am Soc Nephrol 12 2000 1010 1016
131. P. Gines, V. Arroyo, and E. Quintero Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites: results of a randomized study Gastroenterology 93 1987 234 241
132. F. Salerno, S. Badalamenti, and P. Incerti Repeated paracentesis and I.V. albumin infusion to treat "tense" ascites in cirrhotic patients. A safe alternative therapy J Hepatol 5 1987 102 108
133. G. Fernandez-Esparrach, M. Guevara, and P. Sort Diuretic requirements alter therapeutic paracentesis in non-azotemic patients with cirrosis: a randomized double-blind trial of spironolactone versus placebo J Hepatol 26 1997 614 620
134. M. Epstein Peritovenous shunt in the management of ascites and the hepatorenal syndrome Gatroenterology 82 1982 790 799
135. K.A. Somberg, J.R. Lake, S.J. Tomlanovich, J.M. Laberge, V. Feldstein, and N.M. Bass Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function Hepatology 21 1995 709 716
136. F. Wong, K. Sniderman, P. Liu, and L. Blendis The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt Gastroenterology 112 1997 899 907
137. F. Wong, K. Sniderman, P. Liu, Y. Allidina, M. Sherman, and L. Blendis Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory asscites Ann Intern Med 122 1995 816 822
138. P. Angeli, M. Dalla Pria, and E. De Bei Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites Hepatology 19 1994 72 79